期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | OPHTHALMOLOGY LetPub Score 9.0
50 ratings
Rate
Reputation 9.9 Influence 8.3 Speed 9.1 | ||||||||||||||||
期刊簡稱 | OPHTHALMOLOGY | ||||||||||||||||
ISSN | 0161-6420 | ||||||||||||||||
E-ISSN | 1549-4713 | ||||||||||||||||
h-index | 217 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 3.80%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.aaojournal.org/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/OPHTHA | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1978 | ||||||||||||||||
每年文章數 | 132每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 29.38% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0161-6420%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Fast, 2-4 Week(s) 來自Elsevier的數據: Average 3.8 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Very difficult 來自Elsevier的數據: 26% | ||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 16.7 Week(s) | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[OPHTHALMOLOGY] 的評論 | 撰寫評論 |
作者: 北国梦轩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-17 08:40:56 評論於 Can I file a case?(0) 讚! | 北国梦轩 |
作者: 墟散寄蓉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-03-06 20:24:57 評論於 Can this journal have surgical videos?(0) 讚! | 墟散寄蓉 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:40:59 評論於 The introduction should outline the challenges you want to address and the questions you want to answer, summarizing existing research and gaps in knowledge(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 12:12:15 評論於 Introduction writing focuses on identifying the problems to be solved and the innovative or valuable aspects of one's own research. Discussion讨论部分, needs to make a detailed comparison and analysis of the advantages and disadvantages of one's own research results with those of previous researchers. Both focus points are different(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 13:23:47 評論於 Introduction and discussion how to write without repeating?(0) 讚! | 平原文波 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:50:19 評論於 How to write an introduction? How does it differ from the discussion?(0) 讚! | 深渊兴业 |
作者: 春玲小仙女 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-04-17 10:03:13 評論於 Can I submit a cas e for the same question?(0) 讚! | 春玲小仙女 |
作者: 凤凰院乙未 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-04 15:02:43 評論於 Can I submit a case report? emmons 2015-12-02 11:00:00 Posted: This journal is quite annoying and seriously discriminates against the research results of Chinese people. They publish simple things done by foreigners, but domestically made things are very difficult, and the quality of foreigners is also very poor(0) 讚! | 凤凰院乙未 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-16 10:50:48 評論於 Rise is just a word, welcoming the rise. Looking at this trend, breaking through 10 points in the future is in sight! I am in Anhui, can I send one, satisfied(0) 讚! | 凌霄高洁 |
作者: 百花冰海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-19 17:42:30 評論於 Review speed: 3.0, Experience sharing: Not good, this journal is quite bad, seriously discriminating against Chinese research results(0) 讚! | 百花冰海 |
作者: Anonymous 領域: 医药科学 審稿時間: 3.0 month(s) 結果: 拒稿 撰寫評論 |
2016-08-19 11:08:37 評論於 Very hard for international researchers to get papers accepted in this journal. (0) 讚! | Anonymous |
作者: 形意耕顺 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-12-02 13:21:51 評論於 Review speed: 6.0 | Submission acceptance rate: 5.0 Experience sharing: This journal is quite awful, seriously discriminating against the research achievements of the Chinese. They accept submissions of simple things done by foreigners, but consider domestically produced work to be very difficult. The quality of the foreigners is also very poor(0) 讚! | 形意耕顺 |
作者: 孤云平彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-04-21 23:44:27 評論於 Please translate the following passage into English and Japanese, and title them as ":" and ":"(0) 讚! | 孤云平彤 |
作者: 孤云平彤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-04-19 16:00:14 評論於 Please translate the following passage into English and Japanese, and use ":" and ":" as headings(0) 讚! | 孤云平彤 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-07-08 12:45:42 評論於 SCI(2011): 5.45(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-10-19 23:19:30 評論於 I revised it on time in January, very carefully and meticulously. I revised it multiple times, and the final revision was just to change the punctuation(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-02-05 14:11:16 評論於 High emphasis is placed on the novelty of the topic and its clinical relevance(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2009-09-15 23:48:05 評論於 Color figures are free for one page, with a fee of $650 to $1200 for each additional page; no page charges. Initial submission to first revision is due in March, with a 90-day revision period. Second submission to final revision is due in February, proof in January, online at press in March, and officially published in January. High standards are required, usually original and may cover a wide range of subjects (content that can guide most ophthalmologists), making it easier to publish(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us